ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
AHJ Danser, WW Batenburg… - Pharmacology & …, 2007 - Elsevier
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
AHJ Danser, WW Batenburg… - Pharmacology & …, 2007 - pubmed.ncbi.nlm.nih.gov
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
[引用][C] ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE …
AHJ Danser, WW Batenburg… - Pharmacology & …, 2007 - elibrary.ru
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
AHJ Danser, WW Batenburg… - Pharmacology and …, 2007 - infona.pl
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
AH Danser, WW Batenburg… - Pharmacology & …, 2006 - europepmc.org
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
[引用][C] ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE …
D AH - Pharmacol Ther, 2007 - cir.nii.ac.jp
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does
ACE genotyping not predict the therapeutic efficacy of ACE inhibition? | CiNii Research CiNii …
ACE genotyping not predict the therapeutic efficacy of ACE inhibition? | CiNii Research CiNii …
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
J Danser, W Batenburg, A van den Meiracker… - Pharmacology & …, 2007 - repub.eur.nl
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
AHJ Danser, WW Batenburg… - Pharmacology and …, 2007 - infona.pl
Angiotensin (Ang)-converting enzyme (ACE) inhibitors are widely used for the treatment of
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …
cardiovascular diseases. Not all patients respond to ACE inhibitors, and it has been …